Health-related quality of life in patients with newly diagnosed multiple myeloma ineligible for stem cell transplantation: results from the randomized phase III ALCYONE trial — Stefan Knop (2021) | RDL Network
Health-related quality of life in patients with newly diagnosed multiple myeloma ineligible for stem cell transplantation: results from the randomized phase III ALCYONE trial
Jessica C. Levenson, Bruce L. Rollman, Lee M. Ritterband, Patrick J. Strollo, Kenneth J. Smith, Jonathan G. Yabes, Charity G. Moore, Allison G Harvey, Daniel J. Buysse
Gabriel Tremblay, Patrick Daniele, Janis L. Breeze, Lingling Li, Jatin J. Shah, Sharon Shacham, Michael Kauffman, Monika Engelhardt, Ajaj Chari, Ajay K. Nooka, Dan T. Vogl, Maria Gavriatopoulou, Meletios A Dimopoulos, Paul G. Richardson, Noa Biran, David S. Siegel, Philip Vlummens, Chantal Doyen, Thierry Façon, Mohamad Mohty, Nathalie Meuleman, Moshe Levy,
Meletios A Dimopoulos, Ivan Špıčka, Hang Quach, Albert Oriol, Roman Hájek, Mamta Garg, Meral Beksaç, Sara Bringhen, Eirini Katodritou, Wee Joo Chng, Xavier Leleu, Shinsuke Iida, María‐Victoria Mateos, Gareth J. Morgan, Alexander Vorog, Richard Labotka, Bingxia Wang, Antonio Palumbo, Sagar Lonial
Alessandra Tedeschi, Constantine S. Tam, Roger G. Owen, Christian Buske, Véronique Leblond, Meletios A Dimopoulos, Ramón García‐Sánz, Jorge J. Castillo, Judith Trotman, Steven P. Treon, Keri Yang, Boxiong Tang, Heather Allewelt, Sheel Patel, Wai‐Yee Chan, Aileen Cleary Cohen, Shengnan Chen, Gisoo Barnes
Discussion(0)
No comments yet. Be the first to comment.